Huntington National Bank’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.78K | Sell |
270
-423
| -61% | -$5.92K | ﹤0.01% | 2079 |
|
|
2025
Q1 | $9.42K | Buy |
693
+100
| +17% | +$1.36K | ﹤0.01% | 1772 |
|
|
2024
Q4 | $12.1K | Buy |
593
+122
| +26% | +$2.49K | ﹤0.01% | 1710 |
|
|
2024
Q3 | $13.7K | Buy |
471
+26
| +6% | +$757 | ﹤0.01% | 1639 |
|
|
2024
Q2 | $10.3K | Buy |
445
+71
| +19% | +$1.65K | ﹤0.01% | 1679 |
|
|
2024
Q1 | $7.67K | Buy |
374
+24
| +7% | +$492 | ﹤0.01% | 1774 |
|
|
2023
Q4 | $7.51K | Sell |
350
-5
| -1% | -$107 | ﹤0.01% | 1747 |
|
|
2023
Q3 | $7.32K | Sell |
355
-98
| -22% | -$2.02K | ﹤0.01% | 1678 |
|
|
2023
Q2 | $13.4K | Sell |
453
-4
| -0.9% | -$118 | ﹤0.01% | 1481 |
|
|
2023
Q1 | $10.5K | Buy |
457
+116
| +34% | +$2.67K | ﹤0.01% | 1513 |
|
|
2022
Q4 | $9.48K | Sell |
341
-6
| -2% | -$167 | ﹤0.01% | 1506 |
|
|
2022
Q3 | $11K | Buy |
347
+209
| +151% | +$6.63K | ﹤0.01% | 1492 |
|
|
2022
Q2 | $4K | Hold |
138
| – | – | ﹤0.01% | 1766 |
|
|
2022
Q1 | $4K | Buy |
138
+7
| +5% | +$203 | ﹤0.01% | 1791 |
|
|
2021
Q4 | $6K | Buy |
131
+1
| +0.8% | +$46 | ﹤0.01% | 1685 |
|
|
2021
Q3 | $7K | Buy |
+130
| New | +$7K | ﹤0.01% | 1518 |
|